164 related articles for article (PubMed ID: 35873158)
21. Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
Zhang Z; Ma Q; Zhang L; Ma L; Wang D; Yang Y; Jia P; Wu Y; Wang F
Front Cell Infect Microbiol; 2024; 14():1325500. PubMed ID: 38333037
[TBL] [Abstract][Full Text] [Related]
22. The interplay between human papillomavirus and vaginal microbiota in cervical cancer development.
Sharifian K; Shoja Z; Jalilvand S
Virol J; 2023 Apr; 20(1):73. PubMed ID: 37076931
[TBL] [Abstract][Full Text] [Related]
23. HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources.
Lebeau A; Bruyere D; Roncarati P; Peixoto P; Hervouet E; Cobraiville G; Taminiau B; Masson M; Gallego C; Mazzucchelli G; Smargiasso N; Fleron M; Baiwir D; Hendrick E; Pilard C; Lerho T; Reynders C; Ancion M; Greimers R; Twizere JC; Daube G; Schlecht-Louf G; Bachelerie F; Combes JD; Melin P; Fillet M; Delvenne P; Hubert P; Herfs M
Nat Commun; 2022 Feb; 13(1):1076. PubMed ID: 35228537
[TBL] [Abstract][Full Text] [Related]
24. Vaginal Microbiome Components as Correlates of Cervical Human Papillomavirus Infection.
Andrade Pessoa Morales J; Marconi C; El-Zein M; Ravel J; da Silva Pinto GV; Silveira R; Lima MD; de Carvalho NS; Alves RRF; de Lima Parada CMG; Leite SHM; Villa LL; Franco EL; da Silva MG
J Infect Dis; 2022 Sep; 226(6):1084-1097. PubMed ID: 34718662
[TBL] [Abstract][Full Text] [Related]
25. Vaginal microbiota and personal risk factors associated with HPV status conversion-A new approach to reduce the risk of cervical cancer?
Yang Z; Zhang Y; Stubbe-Espejel A; Zhao Y; Liu M; Li J; Zhao Y; Tong G; Liu N; Qi L; Hutchins A; Lin S; Li Y
PLoS One; 2022; 17(8):e0270521. PubMed ID: 35944043
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study.
Gao W; Weng J; Gao Y; Chen X
BMC Infect Dis; 2013 Jun; 13():271. PubMed ID: 23758857
[TBL] [Abstract][Full Text] [Related]
27. Dysbiosis of vaginal microbiota associated with persistent high-risk human papilloma virus infection.
Mei L; Wang T; Chen Y; Wei D; Zhang Y; Cui T; Meng J; Zhang X; Liu Y; Ding L; Niu X
J Transl Med; 2022 Jan; 20(1):12. PubMed ID: 34980148
[TBL] [Abstract][Full Text] [Related]
28. Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.
Brotman RM; Shardell MD; Gajer P; Tracy JK; Zenilman JM; Ravel J; Gravitt PE
J Infect Dis; 2014 Dec; 210(11):1723-33. PubMed ID: 24943724
[TBL] [Abstract][Full Text] [Related]
29. Cervical cancer and vaginal microbiota changes.
Kovachev SM
Arch Microbiol; 2020 Mar; 202(2):323-327. PubMed ID: 31659380
[TBL] [Abstract][Full Text] [Related]
30. Vaginal microbiome.
Buchta V
Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
[TBL] [Abstract][Full Text] [Related]
31. Does the vaginal microbiota play a role in the development of cervical cancer?
Kyrgiou M; Mitra A; Moscicki AB
Transl Res; 2017 Jan; 179():168-182. PubMed ID: 27477083
[TBL] [Abstract][Full Text] [Related]
32. Vaginal microbiome and cervical cancer.
Kyrgiou M; Moscicki AB
Semin Cancer Biol; 2022 Nov; 86(Pt 3):189-198. PubMed ID: 35276341
[TBL] [Abstract][Full Text] [Related]
33. Genital Tract Infections in an Isolated Community: 100 Women of the Príncipe Island.
Vieira-Baptista P; Grinceviciene S; Bellen G; Sousa C; Saldanha C; Broeck DV; Bogers JP; Donders G
Infect Dis Obstet Gynecol; 2017; 2017():3058569. PubMed ID: 29259388
[TBL] [Abstract][Full Text] [Related]
34. Protease inhibitor effects on prevalence of bacterial vaginosis and human papillomavirus-related lesions.
Marques MPC; Pinto AC; Soares LC; Macedo JMB; Dos Santos DF; de Oliveira MAP
J Obstet Gynaecol Res; 2020 Jun; 46(6):899-906. PubMed ID: 32185840
[TBL] [Abstract][Full Text] [Related]
35. [Primary study on the relationship between high-risk HPV infection and vaginal cervical microbiota].
Zhang Z; Zhang D; Xiao BB; Zhang R; Bai HH; Dong HY; Bi H; Liu ZH
Zhonghua Fu Chan Ke Za Zhi; 2018 Jul; 53(7):471-480. PubMed ID: 30078257
[No Abstract] [Full Text] [Related]
36. Vaginosis-associated bacteria and its association with HPV infection.
Romero-Morelos P; Bandala C; Jiménez-Tenorio J; Valdespino-Zavala M; Rodríguez-Esquivel M; Gama-Ríos RA; Bandera A; Mendoza-Rodríguez M; Taniguchi K; Marrero-Rodríguez D; López-Romero R; Ramón-Gallegos E; Salcedo M
Med Clin (Barc); 2019 Jan; 152(1):1-5. PubMed ID: 29544661
[TBL] [Abstract][Full Text] [Related]
37. Gardnerella vaginalis promotes group B Streptococcus vaginal colonization, enabling ascending uteroplacental infection in pregnant mice.
Gilbert NM; Foster LR; Cao B; Yin Y; Mysorekar IU; Lewis AL
Am J Obstet Gynecol; 2021 May; 224(5):530.e1-530.e17. PubMed ID: 33248136
[TBL] [Abstract][Full Text] [Related]
38. HIV susceptibility in women: The roles of genital inflammation, sexually transmitted infections and the genital microbiome.
Mtshali A; Ngcapu S; Mindel A; Garrett N; Liebenberg L
J Reprod Immunol; 2021 Jun; 145():103291. PubMed ID: 33647576
[TBL] [Abstract][Full Text] [Related]
39. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history.
Usyk M; Schlecht NF; Pickering S; Williams L; Sollecito CC; Gradissimo A; Porras C; Safaeian M; Pinto L; Herrero R; Strickler HD; Viswanathan S; Nucci-Sack A; Diaz A; ; Burk RD
Nat Commun; 2022 Jan; 13(1):233. PubMed ID: 35017496
[TBL] [Abstract][Full Text] [Related]
40. Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner.
Doerflinger SY; Throop AL; Herbst-Kralovetz MM
J Infect Dis; 2014 Jun; 209(12):1989-99. PubMed ID: 24403560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
